---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295014348.md"
description: "Arcutis Biotherapeutics shares are trading higher after the company reported better-than-expected Q2 financial results."
datetime: "2026-08-05T20:50:56.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295014348.md)
  - [en](https://longbridge.com/en/news/295014348.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295014348.md)
---

# 

Arcutis Biotherapeutics shares are trading higher after the company reported better-than-expected Q2 financial results.

### Related Stocks

- [ARQT.US](https://longbridge.com/en/quote/ARQT.US.md)

## Related News & Research

- [Arcutis Biotherapeutics director Howard G. Welgus sells 4,730 common shares for $123,835.71](https://longbridge.com/en/news/296400256.md)
- [Did Profitability, Higher 2026 Guidance, and New Commercial Leadership Just Recast Arcutis Biotherapeutics' (ARQT) Investment Narrative?](https://longbridge.com/en/news/295147038.md)
- [Renaissance Technologies Has Taken a New Position in CrowdStrike. What This Means for CRWD Stock.](https://longbridge.com/en/news/296236628.md)
- [Voya Global Advantage and Premium Opportunity Fund declares $0.085 dividend](https://longbridge.com/en/news/296144838.md)
- [A new look and fresh merch are winning customers back at Target as sales rebound](https://longbridge.com/en/news/296379065.md)